Hantz Financial Services, Inc. Vista Gen Therapeutics, Inc. Transaction History

Hantz Financial Services, Inc.

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 Aug 06, 2024	BUY	$1.14 - $2.09 $29,639 - $54,339	26,000 New	26,000 $32,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $645M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Hantz Financial Services, Inc. with notifications on news.